GUIDE.MRD Webinar on From Evidence to Action: Europe’s Opportunity to Personalise Cancer Follow-Up Post Treatment Europe has made major progress in cancer prevention, diagnosis, and treatment and care. Yet follow-up after treatment often remains a critical gap in the cancer pathway. Across Europe, follow-up care can be uniform, uneven and insufficiently personalised. This means relapseRead more
Abstract accepted @ ELCC European Lung Cancer Congress 2026: Abstracts | ESMORead more
Abstract accepted @ EHMA Accueil – EHMARead more
GUIDE.MRD Webinar on Understanding The System: Adoption of Innovative Diagnostics in Oncology Care Session Description: Integrating innovative diagnostics into routine oncology care has the potential to improve how cancer is monitored after treatment—helping clinicians detect early signs of relapse, tailor follow-up care, and avoid unnecessary interventions. However, whether and how these tests reach patients inRead more
GUIDE.MRD partners have attended the American Society of Clinical Oncology (ASCO) meeting in Chicago, May 30 -June 3 (https://www.asco.org/annual-meeting) To all our GUIDE.MRD partners and contributors — thank you for co-creating a shared vision for better follow-up cancer care. Here is the link to the abstract: https://lnkd.in/esRAwZBx We have introduced the Ideal Healthcare Pathway forRead more
The Innovative Health Initiative (IHI) GUIDE.MRD consortium partners met for the 3rd annual general assembly from 05-06 May 2025 in Nice, France. After a warm welcome to the beautiful city of Nice by the Academic Coordinator Klaus Pantel (UKE) and the Project Leader Bristol Myers Squibb (BMS) represented by Trixia Camacho and Luigi Ravagnan, as wellRead more
Register for the GUIDE.MRD Webinar on Notified Bodies’ Roles and Perspectives on IVDR Clinical Performance Studies Session Description: Bringing an innovative diagnostic assay to market is an exciting yet complex journey. Compliance with the In Vitro Diagnostics Regulation (IVDR) is one of the key steps to ensure the safety, performance, and reliability of IVDs. WhatRead more
The Innovative Health Initiative (IHI) GUIDE.MRD Consortium partners met for the 2nd Annual General Assembly hosted by the coordinating institution at the Universitätsklinikum Hamburg Eppendorf (UKE), from 29-30 April 2024 and organized with the support of Innovation Acta S.r.l. (INN-ACTA). After a warm welcome to the beautiful city of Hamburg by the Project Coordinator Klaus Pantel (UKE) and the ProjectRead more
The GUIDE.MRD consortium partners met for the first face-to-face annual meeting hosted by Dr. Núria Malats at CNIO – Spanish National Cancer Research Centre, in Madrid, Spain, from 22-23 October 2023 and organized with the support of Innovation Acta S.r.l. During the first day first day the monthly Steering Committee meeting took place in presence,Read more
GUIDE.MRD has been officially presented to the scientific community at the ESMO meeting in Madrid (20-24 October 2023) Prof. Klaus Pantel, GUIDE.MRD Project Coordinator, and Prof. Ellen Heizer, GUIDE.MRD Work Package 2 Leader, referred to the GUIDE.MRD project in their talks.In addition, a poster dedicated to GUIDE.MRD project has been presented at the ESMO meetingRead more
